Loading...
Loading...
Among the 1 tracked institutional investors we monitor, INM (INMED PHARMACEUTICALS INC) is held with a combined value of $30.29K across 46,973 shares. The largest holder is CITADEL ADVISORS LLC with a position worth $30.29K (0.00% of their portfolio). CITADEL ADVISORS LLC opened a new position in the most recent quarter.
Total Institutional Value
$30.29K
Total Shares Held
46,973
Institutional Holders
1
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | CITADEL ADVISORS LLC | $30.29K | 0.00% | New |
As of the latest SEC 13F filings, CITADEL ADVISORS LLC is the largest institutional holder of INM with a position worth $30.29K, representing 0.00% of their portfolio. In total, 1 institutional investors hold INM with a combined value of $30.29K.
In the most recent quarter, 1 fund opened a new position in INM.
Institutional investors hold $30.29K worth of INM stock across 1 positions. The largest institutional holder is CITADEL ADVISORS LLC with $30.29K in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For INM, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their INM positions.